Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study

349

Citations

26

References

2008

Year

T. Moretto, Terry Ridge, Leigh MacConell, Ted Okerson, Anne M. Wolka, Robert G. Brodows

Clinical Therapeutics

Diabetes ManagementDiabetesPharmacologyClinical TrialsType 2Exenatide MonotherapyParallel-group StudyPharmacotherapyDiabetes ComplicationsDiabetes MellitusMedicine

References

	Year	Citations

Page 1